# Development of a Novel HBV Drug

> **NIH NIH N43** · HBVTECH · 2020 · $299,868

## Abstract

To support the development of therapeutics for hepatitis B virus.

## Key facts

- **NIH application ID:** 10267591
- **Project number:** 75N93020C00045-0-9999-1
- **Recipient organization:** HBVTECH
- **Principal Investigator:** YONG-YUAN ZHANG
- **Activity code:** N43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $299,868
- **Award type:** —
- **Project period:** 2020-08-19 → 2021-08-18

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10267591

## Citation

> US National Institutes of Health, RePORTER application 10267591, Development of a Novel HBV Drug (75N93020C00045-0-9999-1). Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/grant/nih/10267591. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*